The Dopamine Gene Receptors (DRD1-5) Expression Alteration in Psoriasis Patients.

Malihe MohamadianHossein MortazaviMina MakvandFatemeh AhangariHasem Ahangari

Published in: Recent advances in inflammation & allergy drug discovery (2022)

Increased expression of DR2 and DR4 along with decreased expression of DR3 in PBMCs of psoriasis patients not only provide new insight into the pathogenesis of psoriasis but may also be effective in designing future therapeutic strategies attributable to psoriasis.

Keyphrases

end stage renal disease
poor prognosis
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
binding protein
gene expression
patient reported outcomes
long non coding rna
atopic dermatitis
metabolic syndrome
editorial comment
transcription factor
genome wide
current status